相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Abundant expression of BMI1 in follicular lymphoma is associated with reduced overall survival
Naif AlJohani et al.
LEUKEMIA & LYMPHOMA (2018)
When to Stop Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia
Pierre Laneuville
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission
Monica Bocchia et al.
FRONTIERS IN ONCOLOGY (2018)
Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors
Ami B. Patel et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2017)
Treatment-Free Remission: a New Therapeutic Goal in Chronic Myelogenous Leukemia
Ahmed Gamal Elsayed et al.
CURRENT ONCOLOGY REPORTS (2017)
The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains
Mohammad Alzrigat et al.
ONCOTARGET (2017)
miR-15a/miR-16 down-regulates BMI1, impacting Ub-H2A mediated DNA repair and breast cancer cell sensitivity to doxorubicin
Nibedita Patel et al.
SCIENTIFIC REPORTS (2017)
High BCR-ABL/GUSIS Levels at Diagnosis of Chronic Phase CML Are Associated with Unfavorable Responses to Standard-Dose Imatinib
Paolo Vigneri et al.
CLINICAL CANCER RESEARCH (2017)
BMI1 Inhibitors Down-regulate NOTCH Signaling and Suppress Proliferation of Acute Leukemia Cells
Mika Ohtaka et al.
ANTICANCER RESEARCH (2017)
CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors
Amy Hughes et al.
BLOOD (2017)
In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutants
Simona Soverini et al.
BMC CANCER (2016)
Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization
Nicholas C. P. Cross et al.
ANNALS OF HEMATOLOGY (2015)
Natural course and biology of CML
Bradley Chereda et al.
ANNALS OF HEMATOLOGY (2015)
The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study
Mohammad Mohammadi et al.
BMC CANCER (2015)
gDNA Q-PCR for clinical monitoring of CML
Giovanni Porta et al.
CELL CYCLE (2015)
Mechanisms of resistance to BCR-ABL TKIs and the therapeutic strategies: A review
Ke Yang et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients
Giovanni Caocci et al.
EXPERIMENTAL HEMATOLOGY (2015)
Polycomb genes are associated with response to imatinib in chronic myeloid leukemia
Francesco Crea et al.
EPIGENOMICS (2015)
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
Rafael Bejar et al.
BLOOD (2014)
Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia
Harald Herrmann et al.
BLOOD (2014)
BMI1 gene expression in myeloid leukemias and its impact on prognosis
Niveen S. Saudy et al.
BLOOD CELLS MOLECULES AND DISEASES (2014)
DPPIV (CD26) as a novel stem cell marker in Ph plus chronic myeloid leukaemia
Peter Valent et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2014)
One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a hypoxic environment
Elisabetta Rovida et al.
HYPOXIA (2014)
MicroRNA-214 provokes cardiac hypertrophy via repression of EZH2
Tao Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Lethal myelofibrosis induced by Bmi1-deficient hematopoietic cells unveils a tumor suppressor function of the polycomb group genes
Hideyuki Oguro et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
In Search of CML Stem Cells' Deadly Weakness
Francesca Pellicano et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2011)
分享论文
